A 24 h corticosterone exposure exacerbates excitotoxic insult in rat hippocampal slice cultures independently of glucocorticoid receptor activation or protein synthesis

Brain Research
P J MulhollandMark A Prendergast

Abstract

Elevations in circulating concentrations of glucocorticoids (GC) may increase the expression and/or sensitivity of ionotropic transmitter receptors in brain. For example, recent evidence suggests that acute and chronic GC exposure may alter the number and/or function of N-methyl-D-aspartate (NMDA)-type glutamate receptors, effects that may sensitize the brain to excitotoxic insults. The present studies examined the ability of short-term (24 h) corticosterone (CORT) exposure to potentiate NMDA-induced cytotoxicity in rat hippocampal slice cultures. Additional studies evaluated the role of mineralocorticoid (MR) and glucocorticoid receptor (GR) function, as well as de novo protein synthesis, in potentiation of toxicity by corticosterone exposure. Hippocampal slice cultures were exposed to NMDA (20 microM) for 24 h with cytotoxicity assessed by fluorescent detection of propidium iodide uptake. Exposure to NMDA caused significant propidium iodide uptake in each hippocampal region, while 24 h CORT (0.001-1 microM) exposure alone did not significantly increase propidium iodide uptake. Co-exposure of cultures to CORT and NMDA synergistically increased propidium iodide uptake in each hippocampal region, effects that were prevented by c...Continue Reading

References

Jan 1, 1992·Progress in Nucleic Acid Research and Molecular Biology·A C CatoP Herrlich
Dec 1, 1992·Molecular and Cellular Endocrinology·M WehlingM Christ
Sep 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·A C CatoP Herrlich
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D S KerrP W Landfield
Apr 1, 1991·Journal of Neuroscience Methods·L StoppiniD Muller
Jan 1, 1990·Progress in Brain Research·R M Sapolsky
Jul 1, 1990·Neuroendocrinology·H C HornerR M Sapolsky
Nov 5, 1990·Brain Research·M P ArmaniniR M Sapolsky
Jun 21, 1988·Brain Research·R M SapolskyW W Vale
Oct 1, 1986·Physiological Reviews·B S McEwenW Rostene
Jan 3, 1994·European Journal of Pharmacology·D E Supko, M V Johnston
Aug 1, 1994·Journal of Neurochemistry·B A Stein-BehrensR M Sapolsky
Aug 1, 1993·Cellular and Molecular Neurobiology·E R de KloetM Joëls
Jan 1, 1997·Annual Review of Physiology·M Wehling
Apr 1, 1997·Journal of Neurochemistry·J H PrehnR J Miller
Mar 28, 1997·Molecular and Cellular Endocrinology·S P MalkoskiR I Dorin
Aug 19, 1997·Proceedings of the National Academy of Sciences of the United States of America·S BrookeR Sapolsky
Jan 15, 1998·The New England Journal of Medicine·B S McEwen
Feb 9, 2000·Molecular Cell Biology Research Communications : MCBRC·Y Z Chen, J Qiu
Sep 28, 2001·Biochemical and Biophysical Research Communications·J QiuY Chen

❮ Previous
Next ❯

Citations

Aug 26, 2006·Pharmacology, Biochemistry, and Behavior·Mark A Prendergast, Hilary J Little
Apr 16, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Robert M Wachter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.